Carolina M. Pusec

Carolina M. Pusec

Auto-generated profile, based on publicly available information

Carolina M. Pusec

Department of Neurology, University of Wisconsin Madison, Madison, Wisconsin, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Endocrinology
Verified
Journal Article
Closed access
PDF file
CPCarolina M Pusec
Carolina M Pusec
AJAdam De Jesus
Adam De Jesus
Md. Wasim KhanMd. Wasim Khan
Md. Wasim Khan
ATAlexander R Terry
Alexander R Terry
ALAnton E Ludvik
Anton E Ludvik
BLBRIAN T LAYDEN
BRIAN T LAYDEN
Glucokinase (GCK) is the principal hexokinase (HK) in the liver, operating as a glucose sensor to regulate glucose metabolism and lipid homeostasis. Recently, we proposed Hexokinase Domain Containing-1 (HKDC1) to be a novel 5th HK with expression in the liver. Here, we reveal HKDC1 to have low glucose-phosphorylating ability and demonstrate its association with the mitochondria in hepatocytes. As we have shown previously that genetic deletion of HKDC1 leads to altered hepatic triglyceride levels, we also explored the influence of overexpression of HKDC1 in hepatocytes on cellular metabolism observing reduced glycolytic capacity and maximal mitochondrial respiration with concurrent reductions in glucose oxidation and mitochondrial membrane potential. Furthermore, we found that acute in vivo overexpression of HKDC1 in the liver induced significant changes in mitochondrial dynamics. Altogether, these findings suggest overexpression of HKDC1 causes mitochondrial dysfunction in hepatocytes. However, its overexpression was not enough to alter energy storage in the liver, but led to mild improvement in glucose tolerance. We next investigated the conditions necessary to induce HKDC1 expression, observing HKDC1 expression to be elevated in human patients whose livers were at more advanced stages of NAFLD and similarly found high liver expression in mice on diets causing high levels of liver inflammation and fibrosis. Overall, our data suggests HKDC1 expression in hepatocytes results in defective mitochondrial function and altered hepatocellular metabolism and speculate that its expression in liver may play a role in the development of NAFLD.

3 May 2013 in Journal of Comparative Physiology B
Verified
Journal Article
Closed access
PDF file
CJCatherine L Jarrett
Catherine L Jarrett
MLMateja Lekic
Mateja Lekic
CSChristina L. Smith
Christina L. Smith
CPCarolina M. Pusec
Carolina M. Pusec
KSKaren L. Sweazea
Karen L. Sweazea

1 January 2026 in Case Reports in Neurological Medicine
Verified
Journal Article
Open access
CPCarolina Pusec
Carolina Pusec
KHKaram Han
Karam Han
KGKrithi Gopinath
Krithi Gopinath
MMMichelle Mackay
Michelle Mackay
ALAlan Lozier
Alan Lozier
ABAnkush Bhatia
Ankush Bhatia
Central nervous system (CNS) World Health Organization (WHO) Grade 2 isocitrate dehydrogenase (IDH)‐mutant astrocytomas are classified as low‐grade gliomas with typically slow growth for many years followed by eventual malignant transformation and death. Here, we present a case of a patient with an IDH‐mutant Grade 2 astrocytoma who developed early radiographic tumor progression per Response Assessment in Neuro‐Oncology (RANO) 2.0 as evidenced by new enhancement on MRI T1 postcontrast 4 months after initiation of an IDH inhibitor. Subsequent re‐resection, one month later (or five months postinitiation of ivosidenib treatment), of the enhancing signal retained the Grade 2 designation without any histological or molecular progression per CNS WHO 2021 criteria. Specifically, the Ki‐67 proliferative index remained stable at approximately 2%, and copy number alterations were largely unchanged, including no CDKN2A/B homozygous deletion and relatively low chromosome copy number complexity. On histological examination, there was no elevation in mitotic activity and no features of necrosis or microvascular proliferation to suggest a more aggressive phenotype. The tumor demonstrated increased gemistocytic morphology and rare foci of foamy macrophages, as compared to prior. Following the second resection, the patient received sequential radiation therapy and adjuvant temozolomide chemotherapy treatment and has remained clinically stable on observation with surveillance MRIs for over 18 months. This case highlights the importance of re‐resection in IDH‐mutant gliomas, identifies the potential limitations of the response assessment criteria to differentiate treatment effect from true tumor progression, and emphasizes the need for ongoing investigation into novel genetic alterations, molecular signatures, and histologic markers to more accurately predict radiographic tumor behavior and guide more personalized, targeted treatment strategies for patients with IDH‐mutant gliomas.